ADNRX Holdings — American Beacon ARK Transformational Innovation Fund
All 43 reported holdings of American Beacon ARK Transformational Innovation Fund (ADNRX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Tesla Inc | 10.39% | $16.30M |
| CRISPR Therapeutics AG | 6.19% | $9.71M |
| Tempus AI Inc | 5.13% | $8.04M |
| Shopify Inc | 4.80% | $7.54M |
| Circle Internet Group Inc | 4.53% | $7.10M |
| Coinbase Global Inc | 4.44% | $6.97M |
| Robinhood Markets Inc | 4.27% | $6.70M |
| Advanced Micro Devices Inc | 4.11% | $6.46M |
| Roku Inc | 4.04% | $6.34M |
| ROBLOX Corp | 3.58% | $5.61M |
| Palantir Technologies Inc | 3.58% | $5.61M |
| Beam Therapeutics Inc | 3.40% | $5.33M |
| Twist Bioscience Corp | 2.87% | $4.50M |
| Bullish | 2.73% | $4.28M |
| 10X Genomics Inc | 2.48% | $3.89M |
| Intellia Therapeutics Inc | 2.19% | $3.43M |
| BitMine Immersion Technologies Inc | 2.13% | $3.34M |
| Amazon.com Inc | 2.09% | $3.28M |
| CoreWeave Inc | 2.02% | $3.16M |
| Teradyne Inc | 1.99% | $3.12M |
| NVIDIA Corp | 1.66% | $2.61M |
| Archer Aviation Inc | 1.65% | $2.59M |
| Block Inc | 1.57% | $2.46M |
| Taiwan Semiconductor Manufacturing Co Ltd | 1.40% | $2.20M |
| Illumina Inc | 1.39% | $2.18M |
| Natera Inc | 1.30% | $2.04M |
| American Beacon U.S. Government Money Market | 1.24% | $1.94M |
| Recursion Pharmaceuticals Inc | 1.19% | $1.87M |
| BWX Technologies Inc | 1.12% | $1.76M |
| Deere & Co | 1.07% | $1.68M |
| Meta Platforms Inc | 1.07% | $1.67M |
| Kratos Defense & Security Solutions Inc | 1.06% | $1.66M |
| Veracyte Inc | 1.03% | $1.61M |
| Broadcom Inc | 1.01% | $1.59M |
| Baidu Inc | 0.96% | $1.51M |
| American Beacon U.S. Government Money Market | 0.92% | $1.45M |
| Alibaba Group Holding Ltd | 0.89% | $1.40M |
| GeneDx Holdings Corp | 0.87% | $1.37M |
| Alphabet Inc | 0.87% | $1.36M |
| SoFi Technologies Inc | 0.62% | $972.35K |
| Figma Inc | 0.58% | $904.62K |
| Pacific Biosciences of California Inc | 0.48% | $759.98K |
| Cerus Corp | 0.32% | $503.75K |
ADNRX overview: performance, fees, allocation and SEC filings